Remote Monitoring System for Patients, Who Had Myocardial Infarction
Creation and Evaluation of the Effectiveness of the Remote Monitoring System for Patients, Who Had Myocardial Infarction
1 other identifier
interventional
250
1 country
1
Brief Summary
one-centered, open, prospective, non-randomized, controlled clinical study will be aimed at creating remote monitoring system for patients' condition and the development of methodological approaches and its usage for conducting patients, who had myocardial infraction and who has a very high risk of developing an unfavorable outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 3, 2018
CompletedFirst Submitted
Initial submission to the registry
June 5, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedNovember 9, 2021
August 1, 2021
3.2 years
June 5, 2020
November 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
cardiovascular mortality
the number of deaths from cardiovascular causes
12 months
acute myocardial infarction
incidence of acute myocardial infarction
12 months
cerebral stroke
incidence of cerebral stroke
12 months
revascularization
frequency of repeated revascularization of coronary arteries
12 months
hospitalization
frequency of hospitalization about the progression of coronary heart disease
12 months
Study Arms (2)
The remote monitoring system
EXPERIMENTALA group of patients, who had myocardial infraction and who has a very high risk of developing an unfavorable prognosis, which are followed up in the local outpatient department according to existing clinical recommendations and using remote monitoring system.
Clinical recommendations
NO INTERVENTIONA group of patients, who had myocardial infraction and who has a very high risk of developing an unfavorable prognosis, which are followed up in the local outpatient department according to existing clinical recommendations.
Interventions
Eligibility Criteria
You may qualify if:
- A significant diagnosis of myocardial infraction, confirmed by the level of biomarkers of myocardial necrosis in blood examination (troponin, creatine kinase-MV), electrocardiographic criteria, typical clinical presentation.
- The high level of adherence to treatment
- Signed informed agreement
You may not qualify if:
- Active cancer or remission period less than 5 years;
- Absolute contradictions to the prescription of beta-adrenergic blocking agents, angiotensin converting enzyme inhibitors, statins, antiaggregants.
- Mental illnesses.
- Alcohol and drug abuse
- Patient's noncompliance, according to the researchers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
RyazSMU
Ryazan, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristina Pereverzeva, MD, PhD
RyazSMU
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2020
First Posted
June 9, 2020
Study Start
October 3, 2018
Primary Completion
December 3, 2021
Study Completion
December 31, 2021
Last Updated
November 9, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share